Skip to Content

Published on March 01, 2018

NKCH Offers On-site Gynecologic Oncology Care, Genetic Counseling

Julia A. Chapman, MD, FACOG, a gynecologic oncologist with The University of Kansas Cancer Center, now sees patients on the North Kansas City Hospital campus.

NKCH partners with The University of Kansas Cancer Center and Midwest Cancer Alliance to provide patients access to clinical trials only available at National Cancer Institute-designated cancer centers. Together, they manage and operate the radiation oncology program on the hospital’s campus. Additionally, The University of Kansas Cancer Center manages and operates a medical oncology program adjacent to the radiation oncology facility.

Dr. Chapman, associate professor of gynecologic oncology at the University of Kansas School of Medicine, specializes in diagnosing and treating cervical, ovarian, endometrial and vulvar cancers. She educates patients about their specific cancers so they and their family members can actively participate in the treatment process.

She also works with two integrative physicians to offer patients complementary medicine options along with traditional treatment. She is board certified in obstetrics and gynecology and gynecologic oncology.

Alisdair “Rod” Philp, PhD, a board-certified genetic counselor with The University of Kansas Cancer Center, also now provides services at North Kansas City Hospital. Dr. Philp, who is available one day each week, helps patients understand their risk factors for hereditary cancers so they can make informed healthcare decisions.

Julia Chapman, MD, FACOG

Julia A. Chapman, MDDr. Chapman earned her medical degree and completed her residency in obstetrics and gynecology at the University of California, Irvine. She was a pelvic surgery fellow at Union Memorial Hospital, Baltimore, and gynecologic oncology fellow at the University of California, Irvine.

Alisdair "Rod" Philp, PhD

Rod Philp, PhD Dr. Philp earned his postdoctoral degree in biological sciences from the Imperial College of Science, Technology and Medicine at the University of London, where he was a postdoctoral research fellow. He also was the Henry M. Jackson Foundation Research Fellow at the Uniformed Services University of Health Sciences, Bethesda, Maryland, and a postdoctoral research scholar in ophthalmology at the University of Iowa, Iowa City.